Catalog Home Page

Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: Authorsʼ reply

Phillips, E., Hayden, A., Gutiérrez, S., Jahnke, N., Yip, B., Lima, V.D., Hogg, R.S., Harrigan, P.R. and Montaner, J.S.G. (2008) Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: Authorsʼ reply. AIDS, 22 (4). pp. 548-549.

Link to Published Version: http://dx.doi.org/10.1097/QAD.0b013e3282f4a0ed
*Subscription may be required

Abstract

No abstract available

Publication Type: Journal Article
Murdoch Affiliation: Institute for Immunology and Infectious Diseases
Publisher: Lippincott Williams & Wilkins Ltd.
Copyright: © 2008 Lippincott Williams & Wilkins, Inc.
URI: http://researchrepository.murdoch.edu.au/id/eprint/15272
Item Control Page Item Control Page